disorientation; fatigue; could not get out of bed for 3 days; woke up from sleep with fever; chest pain; swollen joints; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), on 16Feb2021 as dose 2, single (Lot number: EN6201) at the age of 72 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure" (unspecified if ongoing); "Allergies" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension; WIXELA INHUB taken for hypersensitivity, start date: 2017. Vaccination history included: BNT162b2 (1st dose was in the left arm and was given on 26Jan2021, Lot EL9261, expiration unknown. She had minor face flushing like an allergy but it was not significant and not reportable.  No medical treatment. She did not provide date and outcome.), administration date: 26Jan2021, when the patient was 72-year-old, for COVID-19 immunization, reaction(s): "minor face flushing". The following information was reported: CHEST PAIN (non-serious) with onset 16Feb2021, outcome "recovering"; JOINT SWELLING (non-serious) with onset 16Feb2021, outcome "recovering", described as "swollen joints"; PYREXIA (non-serious) with onset 16Feb2021, outcome "recovering", described as "woke up from sleep with fever"; MOVEMENT DISORDER (non-serious) with onset 16Feb2021 at 13:15, outcome "recovering", described as "could not get out of bed for 3 days"; DISORIENTATION (medically significant) with onset 16Feb2021 at 13:15, outcome "recovering"; FATIGUE (non-serious) with onset 16Feb2021 at 13:15, outcome "recovering". The patient underwent the following laboratory tests and procedures: Echocardiogram: done and has grade 2 LV diastolic dysfunction, notes: echocardiogram was done and has grade 2 LV diastolic dysfunction.  Follow-up (10May2022): This is a spontaneous follow-up report from the same contactable Consumer. This 74-year-old female Consumer (patient) reported that: Updated Information included: No new information added  Clinical Course: It was reported that the patient said she wanted to know who saw information when a patient submits a VAERS type report to Pfizer, who gets to see it, and is it automatically sent to the CDC, like does the CDC get these VAERS reports, do they become part of VAERS and CDC records? Reference number: J0XT5FE9 Caller says she has no expiry date or NDC to provide for first, second, or third dose, these were not provided on any of the vaccine doses on her vaccine card. Caller declines to provide LOT/Batch numbers for her first, second, and third doses of the vaccine. She says she has heart damage and is exhausted and has already provided way more details than she should need to do. Caller says law requires that doctors submit a VAERS report for adverse events, which she believed was true until yesterday when she found the Pfizer vaccine adverse event reporting portal as an alternate route for reports by patients, that she was glad to find. She says she would like to know, is it mandatory for Pfizer to report VAERS statistics, since it is set up and would be a good process if that information sees the light of day or is added to CDC overall information and used with VAERS. Caller says she would want to request an email back with information about what the process is, and find out since it is important to know what to tell doctors since many of them now are overwhelmed and could have people deal with Pfizer portal for the VAERS reporting, she needs to know that that this would be a legitimate way that they could be counted. Caller says she has not been able to submit the information to the CDC, if this had been possible, she wants to know what the requirements are for CDC receiving these reports, since the health care professionals are exhausted and it is overwhelming. Caller says she wants to know what examples there are or if there is a way she could be guided to locating further information on the website.   Follow-up 10May2022): This is a spontaneous follow-up report from a contactable consumer. This reporter reported for a patient that: Updated information included: Lab date (echocardiogram was done and has grade 2 LV diastolic dysfunction).  No follow-up attempts are possible. No further information expected.